Literature DB >> 12933895

Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans.

Carmelo Biondo1, Concetta Beninati, Mauro Bombaci, Luciano Messina, Giuseppe Mancuso, Angelina Midiri, Roberta Galbo, Giuseppe Teti.   

Abstract

A 25-kDa cryptococcal deacetylase (d25) was found here to induce cell proliferation, as well as secretion of interleukin 2 and gamma interferon, but not interleukin 4, in spleen cells from d25-immunized or Cryptococcus neoformans-infected mice. The gamma interferon, but not the interleukin 2, response was required for the protective activities of d25 immunization in a murine cryptococcosis model.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12933895      PMCID： PMC187367          DOI： 10.1128/IAI.71.9.5412-5417.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  22 in total

1.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 2.  Cryptococcal immunity and immunostimulation.

Authors:  J W Murphy
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

3.  Early T cell unresponsiveness in mice with candidiasis and reversal by IL-2: effect on T helper cell development.

Authors:  R Spaccapelo; G Del Sero; P Mosci; F Bistoni; L Romani
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

Review 4.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.

Authors:  Chao Huang; Shu-Hua Nong; Michael K Mansour; Charles A Specht; Stuart M Levitz
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.

Authors:  E D Spitzer; S G Spitzer; L F Freundlich; A Casadevall
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

7.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.

Authors:  K L Buchanan; J W Murphy
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

9.  CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans.

Authors:  J O Hill; K M Aguirre
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

10.  Antibodies to interleukin 2. Effects on immune responses in vitro and in vivo.

Authors:  A Granelli-Piperno; L Andrus; E Reich
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307
View more
  10 in total

1.  Fusion of a novel genetically engineered chitosan affinity protein and green fluorescent protein for specific detection of chitosan in vitro and in situ.

Authors:  Malathi Nampally; Bruno Maria Moerschbacher; Stephan Kolkenbrock
Journal:  Appl Environ Microbiol       Date:  2012-02-24       Impact factor: 4.792

2.  Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans.

Authors:  Lorina G Baker; Charles A Specht; Maureen J Donlin; Jennifer K Lodge
Journal:  Eukaryot Cell       Date:  2007-03-30

Review 3.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

4.  Characterization of two novel cryptococcal mannoproteins recognized by immune sera.

Authors:  Carmelo Biondo; Luciano Messina; Mauro Bombaci; Giuseppe Mancuso; Angelina Midiri; Concetta Beninati; Valentina Cusumano; Elisabetta Gerace; Salvatore Papasergi; Giuseppe Teti
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 5.  Virulence-Associated Enzymes of Cryptococcus neoformans.

Authors:  Fausto Almeida; Julie M Wolf; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2015-10-09

Review 6.  A Call to Arms: Quest for a Cryptococcal Vaccine.

Authors:  Marley C Caballero Van Dyke; Floyd L Wormley
Journal:  Trends Microbiol       Date:  2017-11-02       Impact factor: 17.079

7.  Fungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity.

Authors:  Sophie Lev; Cecilia Li; Desmarini Desmarini; Adolfo Saiardi; Nicole L Fewings; Stephen D Schibeci; Raghwa Sharma; Tania C Sorrell; Julianne T Djordjevic
Journal:  mBio       Date:  2015-06-02       Impact factor: 7.867

8.  Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.

Authors:  Charles A Specht; Chrono K Lee; Haibin Huang; Donald J Tipper; Zu T Shen; Jennifer K Lodge; John Leszyk; Gary R Ostroff; Stuart M Levitz
Journal:  MBio       Date:  2015-12-22       Impact factor: 7.867

9.  Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.

Authors:  Charles A Specht; Chrono K Lee; Haibin Huang; Maureen M Hester; Jianhua Liu; Bridget A Luckie; Melanie A Torres Santana; Zeynep Mirza; Payam Khoshkenar; Ambily Abraham; Zu T Shen; Jennifer K Lodge; Ali Akalin; Jane Homan; Gary R Ostroff; Stuart M Levitz
Journal:  mBio       Date:  2017-11-28       Impact factor: 7.867

10.  Cryptococcus neoformans Cda1 and Its Chitin Deacetylase Activity Are Required for Fungal Pathogenesis.

Authors:  Rajendra Upadhya; Lorina G Baker; Woei C Lam; Charles A Specht; Maureen J Donlin; Jennifer K Lodge
Journal:  mBio       Date:  2018-11-20       Impact factor: 7.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.